The Inspire Corporate Bond ETF (IBD), a $422.1 million smart beta fund tracking an equal-weighted index of 250 investment-grade corporate bonds, has delivered a 5.67% year-to-date return and 4.14% over the past 12 months. However, its 0.43% annual operating expense ratio is noted as one of the highest in its segment, leading to the assessment that it is not a suitable option for investors seeking outperformance, with more cost-effective alternatives available in the Investment Grade Corporate Bond ETF market.
The Inspire Corporate Bond ETF (IBD) is a mid-sized, smart beta fund with $422.1 million in assets, offering exposure to an equal-weighted index of 250 investment-grade corporate bonds from thematically-selected 'inspiring' companies. While the fund has delivered a positive year-to-date return of 5.67% and a 12-month return of 4.14%, its primary drawback is a high annual operating expense ratio of 0.43%, which is explicitly noted as one of the most expensive in its category. This high cost leads to a moderately negative sentiment and the direct conclusion that IBD is not a suitable option for investors seeking to outperform its segment. The fund maintains a low market correlation with a beta of 0.20 and offers a 4.19% trailing dividend yield, but it is contrasted with significantly larger and more cost-effective ESG-focused alternatives like ESGV (0.09% expense ratio) and ESGU (0.15% expense ratio), which are presented as more favorable options.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
moderately negative
Sentiment Score
-0.50
Ticker Sentiment